Is KLRA or PNTG more profitable?

PNTG runs the higher net margin — KLRA at 0.00% versus PNTG at 2.93%.

Kailera Therapeutics, Inc. (KLRA) vs The Pennant Group, Inc. (PNTG)

A side-by-side comparison of Kailera Therapeutics, Inc. and The Pennant Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

KLRA

Kailera Therapeutics, Inc.

$1.40B

$10.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

PNTG

The Pennant Group, Inc.

$1.39B

$39.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — KLRA vs PNTG

growth of $100 · dividends reinvested · last 1y

KLRA -58.3% (-58.3%/yr)PNTG +31.1% (+31.1%/yr)PNTG compounded faster over this window

KLRA PNTG

KLRA vs PNTG: by the numbers

•KLRA is the larger company ($1.40B vs $1.39B market cap).
•PNTG is profitable (2.93% net margin) while KLRA runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	KLRA	PNTG
P/E ratio	N/A	44.39
Forward P/E	N/A	28.63
PEG ratio	N/A	4.41
P/S ratio	N/A	1.26
P/B ratio	1.25	3.87
EV / EBITDA	N/A	25.34
FCF yield	N/A	1.87%

Profitability

Metric	KLRA	PNTG
Gross margin	0.00%	14.79%
Operating margin	0.00%	5.77%
Net margin	0.00%	2.93%
ROE	N/A	9.00%
ROIC	-24.52%	5.22%

Growth (annualized)

Metric	KLRA	PNTG
Revenue CAGR (5Y)	N/A	21.14%
EPS CAGR (5Y)	N/A	8.96%
Total return CAGR (5Y)	N/A	8.88%

Frequently asked

Is KLRA or PNTG more profitable?: PNTG runs the higher net margin — KLRA at 0.00% versus PNTG at 2.93%.

Go deeper

Full KLRA analysis Full PNTG analysis Interactive comparison tool

Dig into the metrics

Pennant P/E ratio Kailera Therapeutics ROE Pennant ROE Kailera Therapeutics operating margin Pennant operating margin Kailera Therapeutics revenue growth Pennant revenue growth Kailera Therapeutics free cash flow Pennant free cash flow

Kailera Therapeutics & Pennant appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.